Despite the efficacy of inhaled corticosteroids and biologics targeting IL-4 or IL-5 in many asthma patients, a significant subset still experiences poor asthma control [6], highlighting the need for complementary therapeutic approaches. The gene discussed is IL4; the disease is asthma.